(Q33569920)

28 July 2017

Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients (English)

1 reference

multicenter clinical trial

28 July 2017

0 references

1 reference

Eleni Daniel

1

0 references

Vasileios Chortis

Vasileios Chortis

7

0 references

Aled Rees

Aled Rees

24

0 references

Niki Karavitaki

Niki Karavitaki

18

0 references

Daniel J. Cuthbertson

Daniel J Cuthbertson

8

0 references

Ashley Grossman

15

Ashley Grossman

1 reference

28 July 2017

Simon Aylwin

2

1 reference

28 July 2017

Omar Mustafa

3

1 reference

28 July 2017

Steve Ball

4

1 reference

28 July 2017

Atif Munir

5

1 reference

28 July 2017

Kristien Boelaert

6

1 reference

28 July 2017

Christina Daousi

9

1 reference

28 July 2017

Surya P Rajeev

10

1 reference

28 July 2017

Julian Davis

11

1 reference

28 July 2017

Kelly Cheer

12

1 reference

28 July 2017

William Drake

13

1 reference

28 July 2017

Kirun Gunganah

14

1 reference

28 July 2017

Mark Gurnell

16

1 reference

28 July 2017

Andrew S Powlson

17

1 reference

28 July 2017

Isabel Huguet

19

1 reference

28 July 2017

Tara Kearney

20

1 reference

28 July 2017

Kumar Mohit

21

1 reference

28 July 2017

Karim Meeran

22

1 reference

28 July 2017

Neil Hill

23

1 reference

28 July 2017

Andrew J Lansdown

25

1 reference

28 July 2017

Peter J Trainer

26

1 reference

28 July 2017

Anna-Elisabeth H Minder

27

1 reference

28 July 2017

John Newell-Price

28

1 reference

28 July 2017

language of work or name

English

0 references

publication date

9 September 2015

1 reference

The Journal of Clinical Endocrinology and Metabolism

28 July 2017

1 reference

28 July 2017

100

1 reference

28 July 2017

11

1 reference

28 July 2017

4146-4154

1 reference

Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Medical treatment of Cushing's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Clinical features and management of ectopic ACTH syndrome at a single institute in Japan

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Inhibition of aldosterone secretion and modification of electrolyte excretion in man by a chemical inhibitor of 11 beta-hydroxylation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Medical therapy of Cushing's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Clinical response to metyrapone as indicated by measurement of mineralocorticoids and glucocorticoids in normal children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Successful long-term treatment of Cushing disease with mifepristone (RU486).

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Cortisol measurement in patients receiving metyrapone therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393433

Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome

31 October 2018

1 reference

12 December 2020

Next Generation Medical Therapy for Cushing's Syndrome—Can We Measure a Benefit?

1 reference

12 December 2020

Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary

1 reference

12 December 2020

Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11 beta-hydroxylation

1 reference

12 December 2020

Metyrapone in long-term management of Cushing's disease

1 reference

12 December 2020

The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome

1 reference

12 December 2020

o,p'-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis

1 reference

12 December 2020

Ketoconazole in Cushing's disease: is it worth a try?

1 reference

12 December 2020

1 reference

12 December 2020

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1210/JC.2015-2616

1 reference

28 July 2017

1 reference

28 July 2017

1 reference